Dergiler / Turkish Neurosurgery / 2018 / Cilt: 28 - Sayı: 3

Outcome of Microsurgical Revascularization in Patients with Moyamoya Disease: First Report from the Iranian Population

Sayfa
394–399
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

As the prevalence of MMD is low in Iranian population, the experience and technique remains in its infancy and further advancements in the field is required.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:AIM: To report the outcome of microsurgical revascularization in patients with Moyamoya Disease (MMD) in Southern Iran.
📊
Temel Bulgular & Veri:MATERIAL and METHODS: This cross-sectional study was conducted in Southern Iran during a 7-year period from 2009 to 2016.
💡
Sonuç & Katkı:As the prevalence of MMD is low in Iranian population, the experience and technique remains in its infancy and further advancements in the field is required.
🔬Tür:Araştırma Makalesi
📍Kapsam:2009 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

AIM: To report the outcome of microsurgical revascularization in patients with Moyamoya Disease (MMD) in Southern Iran. MATERIAL and METHODS: This cross-sectional study was conducted in Southern Iran during a 7-year period from 2009 to 2016. All the patients with Moyamoya Disease (confirmed with digital substraction angiography) who underwent microsurgical revascularization (extracranial-intracranial bypass or synangiosis) were included. All the patients were followed for at least 1 year and the outcome was measured using the Glasgow outcome scale (GOS) and modified Rankin scale (MRS). RESULTS: Overall we included 13 patients with 14 involved hemispheres undergoing direct and indirect revascularization. The mean age of the patients was 20.6±17.5 (ranging from 0.5 to 55) years and there were 5 (38.4%) males and 8 (61.6%) females. We did not have any unfavorable outcome defined as mortality and persistent vegetative state. We performed 12 (85.7%) superficial temporal artery (STA)-middle cerebral artery (MCA) bypass and 2 (14.3%) encephalo-myo-synangiosis (EMS) procedures. The symptoms improved in 7 (53.8%) patients and remained as the preoperative course in 5 (38.5%) patients. Only 1 (7.7%) patient developed immediate postoperative vasospasm and brain swelling, and was managed successfully with decompressive craniectomy and subsequent cranioplasty (GOS=5, MRS=0).CONCLUSION: This is the first study to report the safety, efficacy and outcome of the direct (STA-MCA bypass) and indirect (EMS) revascularization in patients with MMD in the Iranian population. As the prevalence of MMD is low in Iranian population, the experience and technique remains in its infancy and further advancements in the field is required.

🔖

Bu Makaleye Atıf Yap

RAHMANIAN, A., MASOUDI, M. S., GHAFFARPASAND, F., ASHRAF, M. H., ALIBAI, E. (2018). Outcome of Microsurgical Revascularization in Patients with Moyamoya Disease: First Report from the Iranian Population. Turkish Neurosurgery, Cilt: 28 - Sayı: 3, 394–399. https://ajindex.com/articles/405343

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Abdulrauf SI: Cerebral revascularization: Techniques in extracranial-to-intracranial bypass surgery: Expert Consult: Elsevier Health Sciences, 2010 2. Ashrafi MR, Alizadeh H, Yazdani SH, Mohseni M, Mohamadi M: Psychomotor delay, a possible rare presentation of moyamoya disease. Iran J Radiol 8:75-78, 2011 3. Baba T, Houkin K, Kuroda S: Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry 79:900- 904, 2008 4. Cheung AH, Lam AK, Ho WW, Tsang CP, Tsang AC, Lee R, Lui WM, Leung GK: Surgical outcome for Moyamoya disease - clinical and perfusion computed tomography correlation. World Neurosurg 98:81-88, 2017 5. Cho WS, Chung YS, Kim JE, Jeon JP, Son YJ, Bang JS, Kang HS, Sohn CH, Oh CW: The natural clinical course of hemodynamically stable adult moyamoya disease. J Neurosurg 122:82-89, 2015 6. Egashira Y, Yamauchi K, Enomoto Y, Nakayama N, Yoshimura S, Iwama T: Disruption of cortical arterial network is associated with the severity of transient neurological events after direct bypass surgery in adult moyamoya disease. World Neurosurg 100:311-315,2017 7. Esposito G, Kronenburg A, Fierstra J, Braun KP, Klijn CJ, van der Zwan A, et al: "STA-MCA bypass with encephalo-duromyo-synangiosis combined with bifrontal encephalo-duroperiosteal-synangiosis" as a one-staged revascularization strategy for pediatric moyamoya vasculopathy. Childs Nerv Syst 31:765-772, 2015 8. Fujimura M, Bang OY, Kim JS: Moyamoya disease. Front Neurol Neurosci 40:204-220, 2016 9. Fujimura M, Mugikura S, Kaneta T, Shimizu H, Tominaga T: Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease. Surg Neurol 71:442-447, 2009 10. Fujimura M, Tominaga T: Current status of revascularization surgery for Moyamoya disease: Special consideration for its 'internal carotid-external carotid (IC-EC) conversion' as the physiological reorganization system. Tohoku J Exp Med 236:45-53, 2015 11. Gross BA, Du R: The natural history of moyamoya in a North American adult cohort. J Clin Neurosci 20:44-48, 2013 12. Hayashi K, Horie N, Izumo T, Nagata I: A nationwide survey on unilateral Moyamoya Disease in Japan. Clin Neurol Neurosurg 124:1-5, 2014 13. Hu J, Luo J, Chen Q: The susceptibility pathogenesis of the moyamoya disease. World Neurosurg 101:731-741,2017 14. Ilkhchoui Y, Panikkath PV, Martin H: Moyamoya disease, revascularisation surgery and anaesthetic considerations. BM